Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 January 2019 | Story Rulanzen Martin | Photo Sonia Small
Prof Heidi Hudson
Prof Heidi Hudson wants her faculty to embrace the digital era to find that unique ‘KovsieHumanities’.

Ever since her appointment as Dean of the Faculty of the Humanities in March 2018, Prof Heidi Hudson has been on a mission to build relations – and importantly – to find a unique identity for ‘KovsieHumanities’.

“My immediate aim is to consolidate
where things are going well,
and to rectify imbalances and inequities
that developed over time.”
—Prof Heidi Hudson.

 

Prof Hudson is Professor of International Relations with a B2 rating from the National Research Foundation. She was until recently a member of the Committee on the Status of Women in the International Studies Association (ISA), a Global Fellow of the Oslo Peace Research Institute (PRIO) in Norway and is also an elected member of the Academy of Science of South Africa.

 

Critical self-reflection

 

“My immediate aim is therefore to consolidate where things are going well, and to rectify imbalances and inequities that developed over time,” Prof Hudson said. Such a process will require critical self-reflection from all concerned in order to carve out and claim a specific identity and role for the Humanities at the UFS.

 

Research excellence important

 

Research excellence is a major priority for her and plans to enhance research within the faculty will include measures to understand the faculty’s research landscape, addressing uneven productivity and the lack of diversity of our researchers; creating research-ready undergraduate students; increasing and developing postgraduate students; and effectively marketing our Humanities research. 

 

The diversity of the faculty is considered a strength in terms of interdisciplinary and cross-faculty collaboration. “This aspect is also encouraged by the university’s differentiated research strategy where the Humanities will lead and coordinate an African Studies research hub.”

 

Curriculum development and renewal, together with space to actively engage with discipline-specific questions on the decolonisation of the curriculum, is a key priority related to teaching and learning for Prof Hudson. “The approach to curriculum renewal is collaborative, with the recent formation of two programme committees for the generic degrees,” she said.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept